To investigate whether CMKLR1 was the only receptor that could elicit the effect of chemerin in GBM cells, we knocked down three verified receptors of chemerin, GPR1, CMKLR2, and CMKLR1, in chemerin-overexpressing GSCs [27]. The gene discussed is CMKLR1; the disease is glioblastoma.